Your browser is no longer supported. Please, upgrade your browser.
Settings
GSK GlaxoSmithKline plc daily Stock Chart
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E27.00 EPS (ttm)1.47 Insider Own0.20% Shs Outstand2.48B Perf Week2.96%
Market Cap98.23B Forward P/E13.27 EPS next Y2.99 Insider Trans0.00% Shs Float2.45B Perf Month0.15%
Income3.62B PEG3.07 EPS next Q0.88 Inst Own11.40% Short Float0.29% Perf Quarter-5.40%
Sales39.72B P/S2.47 EPS this Y184.00% Inst Trans0.03% Short Ratio2.86 Perf Half Y-0.98%
Book/sh1.98 P/B20.01 EPS next Y1.08% ROA2.90% Target Price43.05 Perf Year-3.41%
Cash/sh2.20 P/C17.99 EPS next 5Y8.80% ROE137.00% 52W Range34.52 - 42.36 Perf YTD11.67%
Dividend2.00 P/FCF63.39 EPS past 5Y-10.10% ROI22.90% 52W High-4.04% Beta0.80
Dividend %5.05% Quick Ratio0.60 Sales past 5Y2.70% Gross Margin68.80% 52W Low17.76% ATR0.60
Employees98462 Current Ratio0.90 Sales Q/Q-0.10% Oper. Margin14.90% RSI (14)57.81 Volatility1.48% 1.15%
OptionableYes Debt/Eq7.63 EPS Q/Q341.10% Profit Margin5.50% Rel Volume2.70 Prev Close39.61
ShortableYes LT Debt/Eq6.68 EarningsOct 24 Payout85.00% Avg Volume2.47M Price40.65
Recom2.60 SMA202.19% SMA501.33% SMA2003.02% Volume819,844 Change2.63%
Oct-09-18Initiated Guggenheim Neutral
Aug-30-18Downgrade Liberum Buy → Hold
Apr-04-18Upgrade Exane BNP Paribas Neutral → Outperform
Mar-22-18Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-09-18Upgrade Kepler Reduce → Hold
Nov-06-17Downgrade Investec Buy → Hold
Oct-26-17Downgrade BofA/Merrill Buy → Neutral
Sep-08-17Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-05-17Downgrade Citigroup Buy → Neutral
May-26-17Upgrade Berenberg Hold → Buy
Apr-05-17Upgrade Exane BNP Paribas Underperform → Neutral
Mar-09-17Initiated Liberum Buy
Mar-09-17Initiated Kepler Reduce
Oct-20-16Initiated Investec Buy
Sep-23-16Initiated Piper Jaffray Overweight
Jul-14-16Upgrade Jefferies Hold → Buy
Mar-30-16Upgrade Citigroup Neutral → Buy
Feb-26-16Initiated Cantor Fitzgerald Hold
Dec-09-15Upgrade BofA/Merrill Neutral → Buy
Dec-07-15Reiterated Argus Buy $52 → $48
Oct-18-18 12:24PM  Better Buy: GlaxoSmithKline plc vs. Eli Lilly Motley Fool
Oct-17-18 07:00AM  NeuroMetrix Reports Q3 2018 Financial Results GlobeNewswire
Oct-15-18 06:04PM  Trump administration: Drug makers should disclose prices in TV ads Yahoo Finance
Oct-08-18 02:50PM  Meet the $172.5 million biotech IPO from the U.K. with big plans to grow in the Bay Area American City Business Journals
Oct-05-18 05:20PM  Meet the $172.5 million biotech IPO from the U.K. with big plans to grow in the Bay Area American City Business Journals
04:42PM  Merck Reports Positive Efficacy Data from Phase III HIV Study Zacks
09:55AM  Gilead Announces Positive Data From Ongoing Biktarvy Study Zacks
Oct-04-18 09:37AM  J&J's Phase III Data Shows Switch to its HIV Drug Beneficial Zacks
Oct-03-18 07:19PM  [$$] Boston Pharma Adds to War Chest in Pacts With Novartis, GlaxoSmithKline The Wall Street Journal
12:33PM  6 of the Best Dividend Stocks Outside the U.S. InvestorPlace
11:26AM  Why Dynavax Technologies Corporation Stock Struggled in September Motley Fool
12:20AM  [$$] Nobel chemistry prize given for work that harnessed evolution Financial Times
Oct-02-18 10:18AM  GSK resumes some doctor payments, backtracking on blanket ban Reuters
Sep-28-18 10:07AM  Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs Zacks
Sep-27-18 09:03AM  Big Pharma Players on Strong Footing Ahead of Q4: 4 Picks Zacks
Sep-26-18 11:14AM  Glaxo's Tuberculosis Vaccine Positive in Mid-Stage Study Zacks
11:10AM  Theravance Up as CHMP Backs Trelegy Elipta Line Extension Zacks
08:50AM  New Research Coverage Highlights Sanofi, Amdocs, GlaxoSmithKline plc, BT Group, Sociedad Quimica y Minera S.A, and ARMOUR Residential REIT Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Sep-25-18 09:30AM  Is GlaxoSmithKline plc (GSK) Stock Outpacing Its Medical Peers This Year? Zacks
Sep-24-18 01:40PM  5 Stocks Jeremy Grantham Keeps Buying GuruFocus.com
Sep-20-18 10:48AM  Top Research Reports for Wells Fargo, Schlumberger & Biogen Zacks
Sep-19-18 10:46AM  AstraZeneca's Fasenra Long-Term Asthma Study Data Positive Zacks
09:35AM  Should Value Investors Consider Glaxo (GSK) Stock Now? Zacks
Sep-18-18 07:57PM  PRESS DIGEST- Financial Times - Sept 19 Reuters
06:36PM  Theravance, Mylan Report Positive Data on COPD Drug Yupelri Zacks
03:15PM  Exclusive: Nestle, Unilever, Coke make bids in $4 billion-plus GSK India sale - sources Reuters
12:34PM  GSK grabs new drug development head from Boehringer Reuters
05:57AM  [$$] Nestlé, Unilever and Coca-Cola bid for GSKs Horlicks unit Financial Times
Sep-17-18 06:30PM  Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV Zacks
08:19AM  Is Artificial Intelligence the Next Big Thing in Biotech? Zacks
Sep-14-18 04:56PM  Chinese scientist pleads guilty in plot to steal GSK secrets Associated Press
10:02AM  Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus Zacks
Sep-13-18 06:31AM  What's Next for Gilead Sciences After Its Latest Clinical Success Motley Fool
Sep-12-18 11:25AM  The Outlook for AstraZeneca Is Positive, But Its Too Early to Pull the Trigger InvestorPlace
Sep-11-18 07:35AM  Coca-Cola May Have a New Target in Its Race for Global Beverage Dominance Motley Fool
Sep-10-18 10:19AM  Glaxo's Nucala Suffers Regulatory Setback, Gets CRL for COPD Zacks
Sep-09-18 07:33AM  3 Top Value Stocks to Buy in September Motley Fool
04:33AM  Coca-Cola Plans to Bid for GSK's Horlicks: Sunday Telegraph Bloomberg
Sep-07-18 06:24PM  GSK says U.S. FDA wants more information on pulmonary drug Reuters
06:17PM  GSK says U.S. FDA wants more information on pulmonary drug Reuters
09:36AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:55AM  The Daily Biotech Pulse: Amgen-AstraZeneca, Boston Scientific Opens Wallet, Advaxis Offering Benzinga
Sep-06-18 07:42AM  Stocks making the biggest move premarket: CBS, XOM, FB, DAL, NAV & more CNBC
01:24AM  Drugmaker GSK to eliminate 650 U.S. jobs Reuters
12:11AM  Decoding the DNA Opportunity with Anne Wojcicki (23andMe) | Disrupt SF 2018 Yahoo Finance Video
Sep-05-18 09:13PM  Glaxo to cut 650 U.S. jobs as part of global restructuring: report MarketWatch
06:19PM  Drugmaker GSK to eliminate 650 U.S. jobs Reuters
05:58PM  23andMe CEO Anne Wojcicki on Glaxo Partnership and Data Security Bloomberg Video
05:57PM  23andMe CEO Anne Wojcicki on Glaxo Partnership and Data Security Bloomberg
05:41PM  23andMe underscores that privacy-loving customers need to opt out of its data deal with GlaxoSmithKline TechCrunch
05:05PM  GlaxoSmithKline cuts 650 jobs across the nation, 100 in RTP American City Business Journals
04:30PM  GlaxoSmithKline cuts 650 jobs across the nation, 100 in RTP American City Business Journals
10:39AM  Merck's Keytruda Gets Priority Review for Rare Skin Cancer Zacks
Sep-04-18 05:17PM  Insurance tactic drags down U.S. drug prices in 2nd qtr -analyst Reuters
03:01PM  Insurance tactic drags down U.S. drug prices in 2nd quarter -analyst Reuters
Sep-03-18 09:40AM  AstraZeneca's Lupus Drug Misses Primary Endpoint in Study Zacks
Sep-02-18 09:41AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Aug-31-18 03:53PM  Merck (MRK) Receives FDA Approval for Two HIV Medicines Zacks
03:06PM  Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates Benzinga
03:00PM  Researcher admits plot to steal GSK secrets to sell in China Associated Press
03:00PM  Researcher admits plot to steal GSK secrets to sell in China Associated Press
11:42AM  Glaxo's Asthma Drug Gets EU Nod for Pediatric Population Zacks
Aug-29-18 09:43AM  Novartis' Tafinlar/Mekinist Combo Gets EU Nod for 3rd Disease Zacks
Aug-28-18 12:00AM  [$$] Big pharma takes a gamble on NHS experiment Financial Times
Aug-27-18 10:52AM  Zai Lab Stock Down, Atopic Dermatitis Candidate Trial Fails Zacks
Aug-25-18 06:16PM  Barron's Picks And Pans: Electronic Arts, GlaxoSmithKline, Microsoft, Tesla And More Benzinga
Aug-24-18 09:40AM  AstraZeneca's Bevespi Unimpressive in Phase III COPD Study Zacks
08:27AM  HPV-related cancer rises, despite higher vaccination rates American City Business Journals
08:16AM  Better Buy: Eli Lilly and Company vs. GlaxoSmithKline Motley Fool
Aug-23-18 10:04AM  J&J to Appeal as Judge Confirms Jury Order in Talc Case Zacks
07:46AM  Stocks making the biggest move premarket: BABA, HRL, PLCE, DECK, WSM & more CNBC
03:03AM  AstraZeneca inhaler lags GSK drug in lung disease trial Reuters
01:29AM  Glaxo Heads for Record in India Ahead of Consumer Business Sale Bloomberg
Aug-22-18 06:26PM  U.S. appeals court says GSK cannot be sued over generic drug suicide Reuters
10:25AM  Better Buy: GlaxoSmithKline PLC vs. Pfizer Motley Fool
Aug-21-18 10:28AM  GSK seeks mid-Sept bids for $4 billion Indian Horlicks unit -sources Reuters
10:25AM  GSK seeks mid-Sept bids for $4 bln Indian Horlicks unit -sources Reuters
10:13AM  Glaxo Stock Up This Year So Far: Will the Rally Continue? Zacks
09:44AM  GSK seeks mid-Sept bids for $4 bln Indian Horlicks unit -sources Reuters
08:47AM  Glaxo Seeks Bids Mid-September for $4 Billion India Sale Bloomberg
08:07AM  The Zacks Analyst Blog Highlights: IBM, Texas Instruments, Glaxo, Simon Property Group and State Street Zacks
Aug-20-18 10:29AM  Top Stock Reports for IBM, Texas Instruments & Glaxo Zacks
Aug-17-18 04:40PM  Jeff Auxier Trims Keurig Dr Pepper, Twenty-First Century Fox Positions GuruFocus.com
09:34AM  Pharma Stock Roundup: Blow for Bayer, FDA Nod for MRK Cancer Drug in New Indication Zacks
04:24AM  Glaxo, J&J's Dual Drug HIV Regimen Succeeds in Phase III Study Zacks
Aug-16-18 07:19AM  Should Gilead Be Worried About This New Monthly HIV Medication? Motley Fool
Aug-15-18 12:42PM  Long-acting injection a shot in the arm for GSK's HIV business Reuters
12:26PM  Commodities slide pulls FTSE to three-and-a-half month closing low Reuters
09:56AM  Long-acting injection a shot in the arm for GSK's HIV business Reuters
07:43AM  Stocks making the biggest moves premarket: M, STZ, EGN, GSK, WMT & more CNBC
04:20AM  [$$] European Corporate Roundup for Wednesday The Wall Street Journal
04:01AM  Long-acting injection a shot in the arm for GSK's HIV business Reuters
03:13AM  [$$] GSK sees positive signs from trials of reduced HIV treatment Financial Times
02:38AM  Long-acting injection boosts hopes for GSK's HIV business Reuters
Aug-14-18 06:02AM  Better Buy: GlaxoSmithKline plc vs. Bristol-Myers Squibb Motley Fool
Aug-13-18 04:12PM  [$$] Orchard Therapeutics Raises $150 Million After GlaxoSmithKline Deal The Wall Street Journal
08:14AM  Orchard raises $150 million to expand after GSK gene therapy deal Reuters
08:08AM  Orchard raises $150 mln to expand after GSK gene therapy deal Reuters
Aug-10-18 01:19PM  The traders weigh in on Square, GlaxoSmithKline and Dropb... CNBC Videos
10:33AM  In $270M Peninsula vaccine company buyout, small players look to be big shots American City Business Journals
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; and a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLCFormer 10% holderJul 30Buy11.00148,8181,636,998624,422Aug 01 06:32 PM
GLAXOSMITHKLINE PLC10% OwnerJul 17Buy12.5080,0001,000,0001,934,006Jul 17 05:01 PM
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy13.00269,2303,499,9903,697,912Jul 03 05:59 PM
GLAXOSMITHKLINE PLC10% OwnerNov 06Buy14.00428,5715,999,9941,854,006Nov 07 07:42 PM